Yi Lun
Shenzhen University(CN)Shenzhen University Health Science Center(CN)
Publications by Year
Research Areas
Lysosomal Storage Disorders Research, Glycogen Storage Diseases and Myoclonus, Biochemical and Molecular Research, Cellular transport and secretion, Carbohydrate Chemistry and Synthesis
Most-Cited Works
- → The pharmacological chaperone isofagomine increases the activity of the Gaucher disease L444P mutant form of β‐glucosidase(2010)158 cited
- → The Pharmacological Chaperone 1-Deoxygalactonojirimycin Reduces Tissue Globotriaosylceramide Levels in a Mouse Model of Fabry Disease(2009)138 cited
- → Lysosomal Dysfunction in a Mouse Model of Sandhoff Disease Leads to Accumulation of Ganglioside-Bound Amyloid-β Peptide(2012)104 cited
- → Co-administration With the Pharmacological Chaperone AT1001 Increases Recombinant Human α-Galactosidase A Tissue Uptake and Improves Substrate Reduction in Fabry Mice(2012)93 cited
- → The Pharmacological Chaperone AT2220 Increases Recombinant Human Acid α-Glucosidase Uptake and Glycogen Reduction in a Mouse Model of Pompe Disease(2012)83 cited
- → Improved efficacy of a next-generation ERT in murine Pompe disease(2019)82 cited
- → Nanobody Conjugates for Targeted Cancer Therapy and Imaging(2021)55 cited
- → The Pharmacological Chaperone AT2220 Increases the Specific Activity and Lysosomal Delivery of Mutant Acid Alpha-Glucosidase, and Promotes Glycogen Reduction in a Transgenic Mouse Model of Pompe Disease(2014)39 cited
- → Coformulation of a Novel Human α -Galactosidase A With the Pharmacological Chaperone AT1001 Leads to Improved Substrate Reduction in Fabry Mice(2015)36 cited
- → Engineering a Self-Assembled Protein Cage for Targeted Dual Functionalization(2024)13 cited